Cargando…
Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report
RATIONALE: Membranous glomerulonephritis (MN) is the leading cause of nephrotic syndrome in adults and is classified as primary or secondary. Secondary MN accounts for 20% to 30% of all MN cases and can arise from a number of conditions, including autoimmune diseases. Recently exostosin 1/exostosin...
Autores principales: | Li, Ling, Yang, Zhi, Tao, Tian, Yang, Mei, Hu, Zhang-Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939150/ https://www.ncbi.nlm.nih.gov/pubmed/33655949 http://dx.doi.org/10.1097/MD.0000000000024887 |
Ejemplares similares
-
The value of repeat biopsy in lupus nephritis flares
por: Narváez, Javier, et al.
Publicado: (2017) -
Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015) -
Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis
por: Zhang, Haitao, et al.
Publicado: (2020) -
Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis: A case report and a systematic review of the literature
por: Fukushima, Kazuhiko, et al.
Publicado: (2022) -
Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort
por: Li, Huixian, et al.
Publicado: (2022)